Warning: The NCBI web site requires JavaScript to function. more...
HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey.
Dumchev KV, Soldyshev R, Qian HZ, Zezyulin OO, Chandler SD, Slobodyanyuk P, Moroz L, Schumacher JE.
Harm Reduct J. 2009 Aug 23;6:23.
Related citations
Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N, Chkhartishvili N, Abutidze A, Gatserelia L, Sharvadze L.
Georgian Med News. 2008 Dec;(165):54-60.
Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.
Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, Renton A, Bobrova N, McDonald T, Parry JV.
Addiction. 2006 Feb;101(2):252-66.
Predictors of self-reported HIV infection among drug injectors in Ukraine.
Booth RE, Mikulich-Gilbertson SK, Brewster JT, Salomonsen-Sautel S, Semerik O.
J Acquir Immune Defic Syndr. 2004 Jan 1;35(1):82-8.
Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B, Narayanan S, Navaratnam V.
Drug Alcohol Rev. 2009 Jul;28(4):447-54.
High risk behaviors of injection drug users registered with harm reduction programme in Karachi, Pakistan.
Altaf A, Shah SA, Zaidi NA, Memon A, Nadeem-ur-Rehman, Wray N.
Harm Reduct J. 2007 Feb 10;4:7.
[Risk factors for hepatitis C among injecting drug users in Oslo].
Dalgard O, Egeland A, Ervik R, Vilimas K, Skaug K, Steen TW.
Tidsskr Nor Laegeforen. 2009 Jan 15;129(2):101-4. Norwegian.
Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y, Qin G, Yin L, Chen K, Qian HZ, Hao C, Liang S, Zhu J, Xing H, Hong K, Shao Y.
AIDS. 2007 Dec;21 Suppl 8:S39-46.
Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.
Platt L, Sutton AJ, Vickerman P, Koshkina E, Maximova S, Latishevskaya N, Hickman M, Bonell C, Parry J, Rhodes T.
Eur J Public Health. 2009 Aug;19(4):428-33. Epub 2009 Apr 5.
Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment.
Todd CS, Nasir A, Stanekzai MR, Fiekert K, Rasuli MZ, Vlahov D, Strathdee SA.
Harm Reduct J. 2011 Aug 25;8:22.
Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
Xia X, Luo J, Bai J, Yu R.
Public Health. 2008 Oct;122(10):990-1003. Epub 2008 May 19. Review.
Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS.
PLoS One. 2008;3(10):e3608. Epub 2008 Oct 31.
Risk of hepatitis C infection among injection drug users in Mizoram, India.
Chelleng PK, Borkakoty BJ, Chetia M, Das HK, Mahanta J.
Indian J Med Res. 2008 Nov;128(5):640-6.
Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.
Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman D, Friedman SR.
Drug Alcohol Depend. 2009 Apr 1;101(1-2):88-91. Epub 2008 Dec 23.
Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemic.
Platt L, Vickerman P, Collumbien M, Hasan S, Lalji N, Mayhew S, Muzaffar R, Andreasen A, Hawkes S.
Sex Transm Infect. 2009 Apr;85 Suppl 2:ii17-22.
High prevalence of HIV infection among injection drug users (IDUs) in Hyderabad and Sukkur, Pakistan.
Altaf A, Saleem N, Abbas S, Muzaffar R.
J Pak Med Assoc. 2009 Mar;59(3):136-40.
Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.
Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Rüütel K, Des Jarlais DC.
Harm Reduct J. 2009 Feb 20;6:3.
Drug abuse in Nepal: a rapid assessment study.
Chatterjee A, Uprety L, Chapagain M, Kafle K.
Bull Narc. 1996;48(1-2):11-33.
Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M; Amsterdam Cohort.
Addiction. 2007 Sep;102(9):1454-62.
Correlates of lending needles/syringes among HIV-seropositive injection drug users.
Metsch LR, Pereyra M, Purcell DW, Latkin CA, Malow R, Gómez CA, Latka MH; for the INSPIRE Study Team.
J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S72-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on